Buparlisib
Buparlisib (BKM120) is a potent and orally bioavailable pan-class I PI3K inhibitor, targeting p110α, β, and δ isoforms. It is widely used in preclinical cancer research, demonstrating activity in both in vitro cell-based assays and in vivo tumor models for studying PI3K pathway dysregulation.
Product Specifications
CAS Number
944396-07-0
Product Name Alternative
NVP-BKM120; BKM-120
Field of Research
Cell Biology
Purity
>98%
Bioactivity
PI3K inhibitor (pan-Class I)
Form
Powder
Solubility
Soluble in DMSO (up to 15 mg/ml)
Smiles
Nc1cc (c (cn1) -c1cc (nc (n1) N1CCOCC1) N1CCOCC1) C (F) (F) F
Molecular Formula
C18H21F3N6O2
Molecular Weight
410.4
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
5- (2,6-Dimorpholin-4-ylpyrimidin-4-yl) -4- (trifluoromethyl) pyridine-2-amine
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RD-HDGF-Mu-01 96 Tests
Mouse Hepatoma Derived Growth Factor (HDGF) ELISA Kit
Sign In for Pricing
View Details RD-HDGF-Mu-02 48 Tests
Mouse Hepatoma Derived Growth Factor (HDGF) ELISA Kit
Sign In for Pricing
View Details 
VAng-Lsx00951-500gEcoli 500 µg (E. coli)
Recombinant Clostridium Perfringens add Protein (aa 1-332) (strain ATCC 13124 / NCTC 8237 / Type A)
Sign In for Pricing
View Details BNUB3646-100 1x 100 µL
MTAP (Tumor Suppressor Marker) (rMTAP/1813), 0.2mg/mL
Sign In for Pricing
View Details